![](/images/general/no_picture/200_user.png)
Joel A Sincavage
Supervisory Patent Examiner (ID: 11124, Phone: (571)272-2610 , Office: P/2910 )
Most Active Art Unit | 2911 |
Art Unit(s) | 2911, 2900, 2901, 2910 |
Total Applications | 4082 |
Issued Applications | 4006 |
Pending Applications | 1 |
Abandoned Applications | 75 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 6617785
[patent_doc_number] => 20100003317
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-07
[patent_title] => 'COMPOSITIONS AND METHODS FOR MEDIATING RNAI IN VIVO'
[patent_app_type] => utility
[patent_app_number] => 12/412206
[patent_app_country] => US
[patent_app_date] => 2009-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 20455
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20100003317.pdf
[firstpage_image] =>[orig_patent_app_number] => 12412206
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/412206 | Compositions and methods for mediating RNAi in vivo | Mar 25, 2009 | Issued |
Array
(
[id] => 5474445
[patent_doc_number] => 20090247611
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-01
[patent_title] => 'METHOD OF TREATING A CANCER WITH A SURVIVIN ANTISENSE OLIGONUCLEOTIDE AND PACLITAXEL'
[patent_app_type] => utility
[patent_app_number] => 12/403561
[patent_app_country] => US
[patent_app_date] => 2009-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4790
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20090247611.pdf
[firstpage_image] =>[orig_patent_app_number] => 12403561
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/403561 | METHOD OF TREATING A CANCER WITH A SURVIVIN ANTISENSE OLIGONUCLEOTIDE AND PACLITAXEL | Mar 12, 2009 | Abandoned |
Array
(
[id] => 5495326
[patent_doc_number] => 20090263354
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-22
[patent_title] => 'Compositions and siRNAs for inhibiting C/EBPbeta'
[patent_app_type] => utility
[patent_app_number] => 12/382182
[patent_app_country] => US
[patent_app_date] => 2009-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 17992
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0263/20090263354.pdf
[firstpage_image] =>[orig_patent_app_number] => 12382182
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/382182 | Compositions and siRNAs for inhibiting C/EBPbeta | Mar 9, 2009 | Abandoned |
Array
(
[id] => 5374836
[patent_doc_number] => 20090312397
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-17
[patent_title] => 'RNAi Modulation Of ApoB And Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/400744
[patent_app_country] => US
[patent_app_date] => 2009-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 41202
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20090312397.pdf
[firstpage_image] =>[orig_patent_app_number] => 12400744
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/400744 | RNAi modulation of ApoB and uses thereof | Mar 8, 2009 | Issued |
Array
(
[id] => 6025833
[patent_doc_number] => 20110053862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-03
[patent_title] => 'COMPOSITIONS COMPRISING SURVIVIN SIRNA AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/921760
[patent_app_country] => US
[patent_app_date] => 2009-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 22436
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20110053862.pdf
[firstpage_image] =>[orig_patent_app_number] => 12921760
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/921760 | COMPOSITIONS COMPRISING SURVIVIN SIRNA AND METHODS OF USE THEREOF | Mar 8, 2009 | Abandoned |
Array
(
[id] => 6003364
[patent_doc_number] => 20110118332
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-19
[patent_title] => 'VIRAL MICRORNA'
[patent_app_type] => utility
[patent_app_number] => 12/736025
[patent_app_country] => US
[patent_app_date] => 2009-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 8265
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20110118332.pdf
[firstpage_image] =>[orig_patent_app_number] => 12736025
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/736025 | Viral microRNA | Mar 2, 2009 | Issued |
Array
(
[id] => 5458775
[patent_doc_number] => 20090258927
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-15
[patent_title] => 'Method for the Modulation of Function of Transcription Factors'
[patent_app_type] => utility
[patent_app_number] => 12/391943
[patent_app_country] => US
[patent_app_date] => 2009-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8687
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20090258927.pdf
[firstpage_image] =>[orig_patent_app_number] => 12391943
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/391943 | Method for the modulation of function of transcription factors | Feb 23, 2009 | Issued |
Array
(
[id] => 6163474
[patent_doc_number] => 20110160282
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-30
[patent_title] => 'NUCLEIC-ACID PHARMACEUTICAL COMPOSITION FOR CANCER THERAPY'
[patent_app_type] => utility
[patent_app_number] => 12/735809
[patent_app_country] => US
[patent_app_date] => 2009-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9576
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20110160282.pdf
[firstpage_image] =>[orig_patent_app_number] => 12735809
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/735809 | NUCLEIC-ACID PHARMACEUTICAL COMPOSITION FOR CANCER THERAPY | Feb 17, 2009 | Abandoned |
Array
(
[id] => 6048790
[patent_doc_number] => 20110207796
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-25
[patent_title] => 'ALPHA-SYNUCLEIN KINASE'
[patent_app_type] => utility
[patent_app_number] => 12/865857
[patent_app_country] => US
[patent_app_date] => 2009-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 35579
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20110207796.pdf
[firstpage_image] =>[orig_patent_app_number] => 12865857
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/865857 | ALPHA-SYNUCLEIN KINASE | Feb 12, 2009 | Abandoned |
Array
(
[id] => 5480181
[patent_doc_number] => 20090203138
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-13
[patent_title] => 'Small Interfering RNAs Targeting Feline Herpes Virus'
[patent_app_type] => utility
[patent_app_number] => 12/370213
[patent_app_country] => US
[patent_app_date] => 2009-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 35220
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20090203138.pdf
[firstpage_image] =>[orig_patent_app_number] => 12370213
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/370213 | Small interfering RNAs targeting feline herpes virus | Feb 11, 2009 | Issued |
Array
(
[id] => 6113961
[patent_doc_number] => 20110190386
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-04
[patent_title] => 'Aptamer Inhibitors of Osteopontin and Methods of Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/867063
[patent_app_country] => US
[patent_app_date] => 2009-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 17654
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20110190386.pdf
[firstpage_image] =>[orig_patent_app_number] => 12867063
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/867063 | Aptamer Inhibitors of Osteopontin and Methods of Use Thereof | Feb 10, 2009 | Abandoned |
Array
(
[id] => 5503014
[patent_doc_number] => 20090163702
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-25
[patent_title] => 'siRNA targeting Myeloid cell leukemia sequence 1'
[patent_app_type] => utility
[patent_app_number] => 12/378164
[patent_app_country] => US
[patent_app_date] => 2009-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 44
[patent_no_of_words] => 28914
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0163/20090163702.pdf
[firstpage_image] =>[orig_patent_app_number] => 12378164
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/378164 | siRNA targeting myeloid cell leukemia sequence 1 | Feb 10, 2009 | Issued |
Array
(
[id] => 5984597
[patent_doc_number] => 20110097335
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-28
[patent_title] => 'ABC TRANSPORTER PROTEIN EXPRESSION INHIBITOR'
[patent_app_type] => utility
[patent_app_number] => 12/935847
[patent_app_country] => US
[patent_app_date] => 2009-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6874
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0097/20110097335.pdf
[firstpage_image] =>[orig_patent_app_number] => 12935847
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/935847 | ABC TRANSPORTER PROTEIN EXPRESSION INHIBITOR | Jan 27, 2009 | Abandoned |
Array
(
[id] => 185320
[patent_doc_number] => 07645744
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-01-12
[patent_title] => 'Compositions and methods for siRNA inhibition of HIF-1 alpha'
[patent_app_type] => utility
[patent_app_number] => 12/359505
[patent_app_country] => US
[patent_app_date] => 2009-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9763
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/645/07645744.pdf
[firstpage_image] =>[orig_patent_app_number] => 12359505
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/359505 | Compositions and methods for siRNA inhibition of HIF-1 alpha | Jan 25, 2009 | Issued |
Array
(
[id] => 5480810
[patent_doc_number] => 20090203767
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-13
[patent_title] => 'INHIBITION STAT-1'
[patent_app_type] => utility
[patent_app_number] => 12/358088
[patent_app_country] => US
[patent_app_date] => 2009-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 11631
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20090203767.pdf
[firstpage_image] =>[orig_patent_app_number] => 12358088
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/358088 | INHIBITION STAT-1 | Jan 21, 2009 | Abandoned |
Array
(
[id] => 5485368
[patent_doc_number] => 20090275133
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-05
[patent_title] => 'ANTISENSE MODULATION OF C-REACTIVE PROTEIN EXPRESSION'
[patent_app_type] => utility
[patent_app_number] => 12/352572
[patent_app_country] => US
[patent_app_date] => 2009-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25457
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20090275133.pdf
[firstpage_image] =>[orig_patent_app_number] => 12352572
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/352572 | Antisense modulation of C-reactive protein expression | Jan 11, 2009 | Issued |
Array
(
[id] => 7555487
[patent_doc_number] => 08067388
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-29
[patent_title] => 'Decoy-containing pharmaceutical compositions and method of using the same'
[patent_app_type] => utility
[patent_app_number] => 12/349824
[patent_app_country] => US
[patent_app_date] => 2009-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 7500
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/067/08067388.pdf
[firstpage_image] =>[orig_patent_app_number] => 12349824
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/349824 | Decoy-containing pharmaceutical compositions and method of using the same | Jan 6, 2009 | Issued |
Array
(
[id] => 6183825
[patent_doc_number] => 20110123538
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-26
[patent_title] => 'COMPOSITION COMPRISING EXPRESSION OR ACTIVITY INHIBITORS OF NINJURIN 1 FOR THE PREVENTION AND TREATMENT OF INFLAMMATORY DISEASE'
[patent_app_type] => utility
[patent_app_number] => 12/999005
[patent_app_country] => US
[patent_app_date] => 2008-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 8513
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20110123538.pdf
[firstpage_image] =>[orig_patent_app_number] => 12999005
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/999005 | COMPOSITION COMPRISING EXPRESSION OR ACTIVITY INHIBITORS OF NINJURIN 1 FOR THE PREVENTION AND TREATMENT OF INFLAMMATORY DISEASE | Dec 23, 2008 | Abandoned |
Array
(
[id] => 5558909
[patent_doc_number] => 20090270486
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-29
[patent_title] => 'HUMAN RNASE III AND COMPOSITIONS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/341442
[patent_app_country] => US
[patent_app_date] => 2008-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13032
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0270/20090270486.pdf
[firstpage_image] =>[orig_patent_app_number] => 12341442
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/341442 | HUMAN RNASE III AND COMPOSITIONS AND USES THEREOF | Dec 21, 2008 | Abandoned |
Array
(
[id] => 8282921
[patent_doc_number] => 08217017
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-07-10
[patent_title] => 'Modulation of insulin like growth factor I receptor expression'
[patent_app_type] => utility
[patent_app_number] => 12/342025
[patent_app_country] => US
[patent_app_date] => 2008-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 19
[patent_no_of_words] => 32167
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12342025
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/342025 | Modulation of insulin like growth factor I receptor expression | Dec 21, 2008 | Issued |